basic sceince research

TRI-SERVICE MULTICENTER NATIONAL DATABASE

CPDR Sites

 

Madigan Army Medical Center
Tacoma, WA

LTC Timothy Brand, MD; MC, USA, Principal Investigator
Tracy Pletcher, Research Data Manager
Contact Info

 

Naval Medical Center San Diego
San Diego, CA

CDR James L'Esperance, MD; MC, USN, Principal Investigator
Audry L'Esperance, Research Data Manager
Jayla Kyaw, Research Data Manager
Contact Info

 

Tripler Army Medical Center
Honolulu, HI

LTC Joseph Sterbis MD; MC, USA, Principal Investigator
Joanna Mor, Research Data Manager
Contact Info

 

Virginia Mason Medical Center
Seattle, WA

Christopher Porter, MD, FACS, Principal Investigator
Katherine Levie, CCRP, Research Data Manager
Contact Info

 

Walter Reed National Military Medical Center
Bethesda, MD

COL (ret) David G. McLeod, MD; MC, JD, Principal Investigator
COL Inger Rosner, MD; MC, USA, Co-Principal Investigator
Sally Elsamanoudi, MPH, Senior Research Data Manager
Faisal Del, Research Data Manager
Mariam Osman, Research Data Manager
Contact Info

 

MNDP Home | MNDP Staff Listing

CURRENT EVENTS


February 2, 2016

CPDR Urology Residents Take Top Awards at 2016 James C. Kimbrough Urological Seminar

Urology Residents conducting research at The Center for Prostate Disease Research (CPDR), Department of Surgery, Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center presented their research at the Residents Competition category of the James C. Kimbrough Urological Seminar, San Diego, 2016.

Read Full Article

 

January 11, 2016

A Novel Gene Alteration Associates with Aggressive Prostate Cancer in African American Men

The USU, Walter Reed-Bethesda and JPC collaborative team, through comprehensive evaluations of matched cohorts of African American and Caucasian American prostate cancers, previously established a higher frequency of ERG alterations in Caucasians (50-70%) and its significantly lower frequency in African Americans (20-25%). These intriguing observations actually provided the rational for the current study focusing on whole genome evaluations of prostate cancers from these two patient populations.

Read Full Article

 

WRNMMC UsToo! Newsletter

Read the FEBRUARY 2016 WRNMMC UsToo! Newsletter

Go to WRNMMC UsToo! Newsletter Archive